Block Listing Application
Application has been made to the
The block listing application relates to 9,034,732 ordinary shares of
It is expected that admission will become effective on or around
When issued, the New Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares of
As at today, there are 54,062,373 Ordinary Shares in issue with one voting right per share. The Company does not hold any shares in treasury. The Company will make six-monthly announcements of the utilisation of the block admission, in line with its obligations under AIM Rule 29 and monthly announcements as to any changes to total voting rights.
Summary of Fundraise Warrant terms
The Company announced on
The Company may serve notice (the 'Notice') on the Fundraise Warrant holder to exercise their Fundraise Warrant in the event that closing mid-market share price of the Company exceeds 15p over a 5-consecutive day period within 12 months of the date of the Fundraise Shares are admitted to trading on AIM ('Notice Event'). In the event the Company serves Notice, any Fundraise Warrants remaining unexercised following the expiry of the length of the period of the Notice will be cancelled.
The Company will notify Fundraise Warrant holders of a Notice Event both in writing and by regulatory notification. Failure to exercise the Fundraise Warrants within the time limit prescribed in the Notice following the Notice Event will result in the cancellation of the Fundraise Warrants that remain unexercised.
As at the date of this notification the Fundraise Warrants remain capable of being exercised at 13p in accordance with the terms of the Warrant Instrument and associated Certificate.
Contact:
Tel: +44 (0) 20 7073 2628
Email: Suzanne.Dilly@valirx.com
Web: www.valirx.com
(C) 2020 Electronic News Publishing, source